Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EmbryoFix-FG
- Development stage
- Unknown
- Lead developer
- MMC Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
EmbryoFix-FG is an oral granule formulation marketed by MMC Pharmaceuticals Ltd (formerly part of MMC Healthcare Ltd) in India. Launched in 2023 as part of the company's "Ferticare" product line, it is specifically indicated for the support and treatment of fetal growth within the context of fertility and reproductive health. The product is distributed in 5g sachets for oral administration. As MMC Pharmaceuticals operates as a Contract Sales and Marketing Organization (CSMO), EmbryoFix-FG is a commercialized formulation rather than a novel developmental compound. While the specific active ingredients and biological targets are not publicly disclosed in the manufacturer's literature, the product is positioned as a therapeutic intervention for improving pregnancy outcomes related to fetal development.
- Brand names
- EmbryoFix-FGEmbryoFix FG GranulesEmbryo FG Granules
- Other names
- EmbryoFix Granules
Beyond the preview
Go deeper on EmbryoFix-FG.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EmbryoFix-FG.